Godrej Industries Ltd
GODREJINDGodrej Industries Ltd's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it.
The sharpest disagreement: annual EPS moved +26.4% against a −6.9% price move — the market has not yet caught up with the delivery.
The price is in a confirmed uptrend (13 weeks in) while the P/BV sits at the 47th percentile of its own 11-year range. Underneath, the last four quarters read deteriorating — profit −27.9% year on year, with the the net margin at 9.6%. What settles it: whether the price catches up with earnings that have already moved.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Godrej Industries Ltd trades at ₹1,127, in a confirmed uptrend and 13 weeks into that stage. That is +0.4% against its own 200-day average. It sits at 55% of a 52-week range of ₹775 to ₹1,418. On relative strength it is currently behind the NIFTY 500 on a trailing-13-week view (1 week and counting).
Today the stock is in a confirmed uptrend — week 13 of stage 2, confirmed. At ₹1,127 it trades +0.4% versus its 200-day average and sits at 55% of its 52-week range (₹775–₹1,418).
Against the market, two honest reads. Cumulative: over the last 10.5 years the stock moved +240% while the NIFTY 500 moved +267% — behind the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (1 week and counting; last ahead the week of 2026-09-04) — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Story check
Godrej Industries Ltd's story is not scored yet against the markers our research file set on 27 June 2026. Where it sits in its own cycle: EARLY_EXPANSION_TO_MID. Still open: If the ₹1,000 Cr capital injection into Godrej Investment Limited fails to generate ROE above the 11.9% consolidated average within 4 quarters, indicating capital misallocation.
Our read, 27 June 2026. A holding company pivoting aggressively into financial services and real estate, showing accelerated earnings momentum while multiple stays compressed.
From the numbers. Below median at 0.9x, smoothed YoY -22.3%, QoQ IMPROVING — early stage. The multiple compression is earnings-driven, making the P/BV of 3.2x historically inexpensive despite absolute richness.
From the price. Price stage 2, week 13 — above its 200-day line, relative strength falling.
From the research. A holding company pivoting aggressively into financial services and real estate, showing accelerated earnings momentum while multiple stays compressed.
🚨 Where they disagree. Below median at 0.9x, smoothed YoY -22.3%, QoQ IMPROVING — early stage. The multiple compression is earnings-driven, making the P/BV of 3.2x historically inexpensive despite absolute richness.
What is proven. A holding company pivoting aggressively into financial services and real estate, showing accelerated earnings momentum while multiple stays compressed.
What is not proven yet. If the ₹1,000 Cr capital injection into Godrej Investment Limited fails to generate ROE above the 11.9% consolidated average within 4 quarters, indicating capital misallocation.
🚨 What would change our mind. If the ₹1,000 Cr capital injection into Godrej Investment Limited fails to generate ROE above the 11.9% consolidated average within 4 quarters, indicating capital misallocation.
🚨 Layer 1 read, 27 June 2026 — DROP. Richly-valued conglomerate holdco betting on an unproven financial-services pivot - the 'cheap compression' claim does not survive the P/BV lens. On the right lens for a holding company, P/BV 3.5x sits at its own median and is absolutely rich, at the 52.5th percentile - not the compressed multiple the thesis asserts - and the price is in a Stage-4 decline with FIIs selling. Profit is rising but lumpily (net profit swung from -25cr to 841cr across recent quarters), and the growth case rests on an unproven Rs1,000cr financial-services injection that still has to clear its cost of funds.
What would change Layer 1’s mind. The Rs1,000cr capital injection into Godrej Investment Ltd generating ROE above the 11.9% consolidated average within four quarters (the timeline's own falsification) AND the P/BV re-compressing below ~2.5x - together that would convert an unproven, richly-priced pivot into a genuine earnings-backed setup worth ranking up.
The test written in advance. If the ₹1,000 Cr capital injection into Godrej Investment Limited fails to generate ROE above the 11.9% consolidated average within 4 quarters, indicating capital misallocation. — the thesis as written as stated by the next result.
The test written in advance. HoldCo Discount Widening — HoldCo Discount Widening Godrej Investment Limited ROA and ROE metrics in FY27 by the next result.
The test written in advance. Leverage Cost on New Debt — Leverage Cost on New Debt Interest expense YoY growth vs PBIT growth in Q1 FY27 by the next result.
What the company does. Q4 FY26 net profit jumped, driving FY26 ROCE up from lower historical bases. PB ratio sits below its median, with YoY trend contracting, despite EPS rising over 8 quarters. Board approved capital injection into Godrej Investment Limited to expand financial services, plus an NCD raise, signaling a capital allocation pivot.
| Dial | Now | Was | Why it matters | Watch line |
|---|---|---|---|---|
| Financial Services Capital Infusion | HIGH | — | Board approved capital injection into Godrej Investment Limited to accelerate financial services growth. | Cost of funds on the NCDs exceeds the yield generated by the financial services portfolio. |
| Estate & Property Development Ramp-up | MEDIUM_HIGH | — | Real estate segment emerging as a primary growth driver, contributing to the revenue expansion. | If the ₹1,000 Cr capital injection into Godrej Investment Limited fails to generate ROE above the 11.9% consolidated average within 4 quarters… |
The dot is where the company is now; the dashed line is the level that would settle the question; a tinted band is where management says it is heading.
🚨 What the surface reading misses. The surface reading is: PB at 3.2x The research reads it further: PB is below median of 3.4x indicating relative cheapness
Lever 1 · Operating leverage — BUILDING. Board approved capital injection into Godrej Investment Limited to accelerate financial services growth. What proves it keeps working: Financial Services Capital Infusion. It stops working if Cost of funds on the NCDs exceeds the yield generated by the financial services portfolio.
Lever 2 · Value-added mix — BUILDING. Real estate segment emerging as a primary growth driver, contributing to the revenue expansion. What proves it keeps working: Estate & Property Development Ramp-up. It stops working if If the ₹1,000 Cr capital injection into Godrej Investment Limited fails to generate ROE above the 11.9% consolidated average within 4 quarters, indicating capital misallocation.
Sources: our stock research file (27 June 2026) · quarterly results through Jun 26. The story check is re-scored every results season; the record below never changes.
| Section | Where it is now | Vs a year ago | The one thing to watch next | Read |
|---|---|---|---|---|
| Margin | 15% | — | Financial Services Capital Infusion |
Revenue For a bank, revenue is everything the franchise earns — interest on the loan book plus fee and other income.
Godrej Industries Ltd reported ₹5,448 Cr of income in the Jun 26 quarter, +22.2% year on year. That is the 8th straight quarter of year-on-year growth. Over 10 years it has compounded at 11.5% a year. The last full year, FY26, came in at ₹22,237 Cr. The last four reported quarters add to ₹23,225 Cr.
FY26 revenue came in at ₹22,237 Cr (+13.1% on the year), capping 10 years at 11.5% compound. The latest quarter (Jun 26) printed ₹5,448 Cr, +22.2% year on year — the 8th consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +16.2% growth against the decade's 11.5% — the current year is running faster than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +16.9% over the last 4 quarters against +19.2%/yr over the last 8 — stabilising; TTM profit +13.8% vs +52.9%/yr — rolling over.
FY26-Q3. Revenue and net profit were steady. Operating margin stabilized. Estate and property development started showing accelerated traction, providing a base for the consolidated revenue expansion. Promoter shareholding peaked, indicating deep insider alignment ahead of the upcoming strategic pivots.
Why-sources: our stock research file (27 June 2026) and the company’s own results for those quarters.
Net margin Net margin — what the bank keeps of every ₹100 of revenue after every cost, provision and tax. It is the cleanest single margin we can read for a lender.
Godrej Industries Ltd's net margin is 9.6% in the Jun 26 quarter, −6.7 percentage points against the same quarter a year ago. That is the widest this company has ever printed on a full-year basis. Across 13 fiscal years the net margin has ranged 3.6% to 10.8%. The current quarter sits inside that band.
Why this happened. The aggressive capital pivot towards financial services indicates management's intent to capture higher spreads and ROE. This deployment is funded partially by the NCD raise, setting up a levered return profile for the subsidiary.
The latest quarter's net margin is 9.6%, −6.7 pp against the same quarter a year ago. Across 13 fiscal years the net margin has ranged 3.6%–10.8%, and FY26's 10.8% is the top of that band — a record year.
Why: the numbers show the net margin move clearly, but the cost lines behind it sit below what we hold — so we state the move without inventing its driver.
Worth repeating from the valuation section: cheap against its own history on record margins is not the same thing as cheap — a record margin flatters every ratio built on top of it.
FY26-Q3. Revenue and net profit were steady. Operating margin stabilized. Estate and property development started showing accelerated traction, providing a base for the consolidated revenue expansion. Promoter shareholding peaked, indicating deep insider alignment ahead of the upcoming strategic pivots.
Why-sources: our stock research file (27 June 2026) and the company’s own results for those quarters.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Godrej Industries Ltd earned ₹523 Cr of net profit in the Jun 26 quarter, −27.9% year on year. Full-year FY26 profit was ₹2,412 Cr. The 10-year compound rate is 22.3%. That is 9.6% of the quarter's revenue. The same quarter a year earlier earned ₹725 Cr. 1 of the last 12 reported quarters were loss-making.
Jun 26 profit was ₹523 Cr, −27.9% year on year. On the full year, FY26 printed ₹2,412 Cr (+29.8%), and the 10-year compound rate is 22.3%.
🚨 Why profit moved: revenue contributed +22.2% and the margin −6.7 pp — the quarter was revenue-led despite a thinner margin.
Pace comparison, last four quarters: profit +22.1% vs revenue +16.2%. Profit is growing faster than sales — fixed costs are being spread over a bigger base, and each extra rupee of revenue drops more to the bottom line.
FY26-Q3. Revenue and net profit were steady. Operating margin stabilized. Estate and property development started showing accelerated traction, providing a base for the consolidated revenue expansion. Promoter shareholding peaked, indicating deep insider alignment ahead of the upcoming strategic pivots.
Why-sources: our stock research file (27 June 2026) and the company’s own results for those quarters.
Asset quality — the ladder Gross NPA is the slice of the loan book where repayments have stopped. Net NPA is what remains after the money already set aside against those loans. Falling is healing; rising is damage arriving.
Loan-book quality history is not available for Godrej Industries Ltd, so this section names the gap rather than estimating a ratio. No gross or net non-performing-asset series is filed in a form this page can read, and none is inferred from the profit line. The income, margin and return sections above carry the evidence this business does report.
We do not hold quarterly loan-book quality numbers for this bank, so this section states that plainly rather than working around it.
Why: loan-book quality is the engine room of a bank, and its drivers — slippages, recoveries, provisioning — sit below what we hold for this name; the sections around it carry the reads we can stand behind.
The loan book We read the loan book through revenue — when the book grows, revenue grows with it. It is a rough proxy, and we say so: rate moves and fee swings can shift it a few points in any one year.
Godrej Industries Ltd's revenue grew +13.1% in FY26 to ₹22,237 Cr, so the book is growing. The latest quarter ran +22.2% year on year. The net margin on that income is 9.6%, −6.7 percentage points against a year ago. Interest income is a proxy for the book; rate moves can shift it a few points in any one year.
FY26 revenue was ₹22,237 Cr, +13.1% on the year, and the latest quarter ran +22.2% year on year. The net margin on that revenue is 9.6% this quarter (−6.7 pp YoY) — growth with a narrowing margin on it.
The synthesis: a lender compounds when the book grows while the margin holds and the loan book stays clean — gross NPA is the loan-quality read we carry here.
Returns on equity and assets Two numbers usually rate a lender: ROE — what it earns on shareholder money — and ROA — what it earns on everything it deploys.
A clean annual return-on-equity ladder is not held for Godrej Industries Ltd. For an insurer especially the standard bank ratios are not the right lens, so this page does not force them onto the filings rather than estimating a series it cannot support. The revenue, margin and ownership sections above and below are the reads this page stands behind.
We do not hold a clean annual return-on-equity series for Godrej Industries Ltd — for an insurer especially, the standard bank ratios are not the right lens, so this page does not force them. The revenue, margin and ownership sections above and below are the reads we stand behind.
The quarterly return-on-equity and return-on-assets curves, which only the second data source carries, are not drawn on this page: its two data sources disagree by up to 28% on reported income across 14 comparable periods. A figure two sources cannot agree on is not drawn — the gap is a decision, not missing data.
Debt
For a bank, borrowings are raw material, not a warning sign — solvency is read through the returns and the loan book. A manufacturer’s debt is a claim against its profits, so the debt-to-equity lens that works everywhere else misleads on a lender and is not applied here.
A manufacturer’s debt is a claim against its profits; a bank’s borrowings are its inventory — money taken in to be lent out. The debt lens that works everywhere else misleads here, so this page does not apply it. The solvency questions for a bank — is the loan book sound, is the equity earning — are read through the loan-book and returns sections above.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
Promoters added 7.5 points of Godrej Industries Ltd over 8 quarters, the biggest move on the register. That takes promoters to 74.6% of the company. Foreign institutions moved −3.5 points over the same window, to 4.6%. The register is read on the four disclosed classes only; nothing is inferred between filings.
The register over the last two years — Promoters: +7.5 points over 8 quarters to 74.6%; Foreign institutions: −3.5 points over 8 quarters to 4.6%; Domestic institutions: −1.5 points over 8 quarters to 3.5%.
Why the register moved: promoters drove it (+7.5 points), absorbed on the other side by foreign institutions (−3.5 points) — steady accumulation by institutions reading the same numbers this page reads.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Godrej Industries Ltd: the Z-score is omitted — it was built for manufacturers, not banks, and applying it here would be theatre. The Z-score was built for manufacturers and is not applied to banks and lenders, so solvency here is read from the capital and asset-quality lines instead.
The safety line in one sentence: the Z-score is omitted — it was built for manufacturers, not banks, and applying it here would be theatre.
Valuation For a bank we price the book, not the earnings: P/BV is what the market pays for each ₹1 of the bank's net worth. A bank below 1× book is priced below the value of what it owns, net of what it owes.
Godrej Industries Ltd trades at 3.4× P/BV, mid-range by its own standards (47th percentile). Its long-run median P/BV is 3.4×, measured across 10.5 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/BV of 3.4× is mid-range by its own standards (47th percentile), against a long-run median of 3.4× measured over 10.5 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
The honest context for that discount: a bank earning about 9% on its equity is worth less per rupee of book, and the market has priced that in rather than overlooked it. The discount closes only if the returns themselves improve.
One caveat before moving on: the net margin is the best this company has ever printed — cheap against its own history on record margins is not the same thing as cheap. If profitability mean-reverts, today's multiple is higher than it looks.
Why the multiple sits where it does: over the past year book value grew while the price moved −6.9% — price and book moved together, holding the multiple in its range.
The price move, decomposed: over 5y, of the +15.0%/yr price move, ~+8.2%/yr came from book-value growth and ~+6.8 pp from the multiple (expanding); over 10y, of the +10.2%/yr price move, ~+14.0%/yr came from book-value growth and ~−3.8 pp from the multiple (compressing). The split is the honest approximate (price return minus book-value growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is unremarkable against its own past, so the story rests on the book-value line underneath it, not the multiple.
A quarterly PEG curve, which only the second data source carries, is not drawn on this page: its two data sources disagree by up to 28% on reported income across 14 comparable periods. A figure two sources cannot agree on is not drawn — the gap is a decision, not missing data.
What the price assumes This reading works the multiple backwards. It asks one question: what yearly rate of profit growth is a buyer at the market price already paying for? The number is the growth rate that makes eleven years of profit — six years growing, then five fading — add up to that day's market price, once each year is discounted at 11% a year.
Solved at its 29 June 2026 price, Godrej Industries Ltd was paying for profit growth of about 10.5% a year. Profit itself has compounded 22.3% a year over the past 10 years. Today the market pays 3.4× P/BV, the 47th percentile of its own 11-year range.
What the two numbers say together. The multiple is unremarkable against its own past, and the growth the price is paying for is below what this company has actually delivered.
How to hold this number: it is a reading of one day's price, taken on 29 June 2026, not a running figure — every other number on this page, the multiple included, is read off the live quote as of 11 September 2026. A higher price is paying for more growth and a lower price for less, so it moves whenever the price does, and this page does not restate it between measurements.
Stage: Mixed Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Godrej Industries Ltd reads as mixed on its fundamental arc. Mixed — growth is normalizing off a hyper-growth base: profit growth has eased from +105.5% at its peak to +13.8% but is still expanding. The read is built from 8 quarters across 3 curves, on partial evidence.
Why it matters: when the curves disagree, the per-curve reads above matter more than any single verdict.
A partial read: at least one curve is short, or the returns curve is not the computed quarterly series — hold the stage word a little more loosely.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +13.1% | +9.9% | +19.0% | +11.5% |
| Profit | +29.8% | +19.3% | +43.9% | +22.3% |
| EPS | +26.4% | +8.3% | +29.9% | +22.7% |
| Share price | −6.9% | +24.5% | +15.0% | +10.2% |
4-Factor Sector Score
55.3/100 — rank 7 of 18 in Finance - Holding Company · 67% evidence confidence
Godrej Industries Ltd scores 55.3 out of 100 against the 18 companies it is compared with in Finance - Holding Company, ranking 7. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
The four contributions add to the total exactly: 19.5 + 12.4 + 5.3 + 18.1 = 55.3. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if ROA rolls over or gross NPA rises while sector-relative strength deteriorates.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Jindal Poly Investment & Finance Company LtdJPOLYINVST | 80.7/100Sector-leading setup80% evidence | ASLEEP | 31.7/35 Income 100% · PAT 100% 81% evidence | 20.7/25 ROA 47.9% · ROE 54.8% · GNPA — 68% evidence | 14.5/20 P/BV 0.65× · P/BV÷ROE 0.01 100% evidence | 13.8/20 RS sector 32.3% · RS bench -4.7% · 1Y 5%0 of 10 weeks ahead 70% evidence |
| Exact sum: 31.7 + 20.7 + 14.5 + 13.8 = 80.7 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence. | ||||||
| 2Kama Holdings LtdKAMAHOLD | 70.7/100Favorable setup82% evidence | ASLEEP | 26.9/35 Income 12.9% · PAT 50.8% 86% evidence | 17.6/25 ROA 7.3% · ROE 12.6% · GNPA — 72% evidence | 18.0/20 P/BV 0.91× · P/BV÷ROE 0.07 100% evidence | 8.2/20 RS sector -0.5% · RS bench -13.4% · 1Y -22.7%0 of 12 weeks ahead 70% evidence |
| Exact sum: 26.9 + 17.6 + 18 + 8.2 = 70.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 3Alembic LtdALEMBICLTD | 63.0/100Mixed-positive evidence88% evidence | TURNING | 9.4/35 Income 8.1% · PAT 1.3% 86% evidence | 18.0/25 ROA 12.2% · ROE 13% · GNPA — 72% evidence | 16.1/20 P/BV 1.09× · P/BV÷ROE 0.08 100% evidence | 19.5/20 RS sector 14.1% · RS bench 12.6% · 1Y 0%5 of 12 weeks ahead 100% evidence |
| Exact sum: 9.4 + 18 + 16.1 + 19.5 = 63 · Decision use: Price leads the evidence: RS versus the benchmark is 12.6%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 4Cholamandalam Financial Holdings LtdCHOLAHLDNG | 60.3/100Mixed-positive evidence70% evidence | TURNING | 20.9/35 Income 17.5% · PAT 24.3% 62% evidence | 15.8/25 ROA — · ROE 17.5% · GNPA — 34% evidence | 16.3/20 P/BV 1.86× · P/BV÷ROE 0.11 100% evidence | 7.3/20 RS sector -6.8% · RS bench -8.3% · 1Y -13.3%3 of 12 weeks ahead 100% evidence |
| Exact sum: 20.9 + 15.8 + 16.3 + 7.3 = 60.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 5TVS Holdings LtdTVSHLTD | 56.3/100Mixed-positive evidence67% evidence | ASLEEP | 24.7/35 Income 31.7% · PAT 49.4% 52% evidence | 16.2/25 ROA — · ROE 30.6% · GNPA — 34% evidence | 10.9/20 P/BV 4.07× · P/BV÷ROE 0.13 100% evidence | 4.5/20 RS sector -5.8% · RS bench -6.9% · 1Y 7%0 of 12 weeks ahead 100% evidence |
| Exact sum: 24.7 + 16.2 + 10.9 + 4.5 = 56.3 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -5.8% and the one-year return is 7%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 6Bajaj Finserv LtdBAJAJFINSV | 56.2/100Mixed-positive evidence67% evidence | BREAKING OUT | 17.9/35 Income 14.5% · PAT 10.5% 52% evidence | 14.8/25 ROA — · ROE 13.2% · GNPA — 34% evidence | 8.0/20 P/BV 3.93× · P/BV÷ROE 0.3 100% evidence | 15.5/20 RS sector 1.8% · RS bench 0.5% · 1Y -5%8 of 12 weeks ahead 100% evidence |
| Exact sum: 17.9 + 14.8 + 8 + 15.5 = 56.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 7Godrej Industries Ltdthis pageGODREJIND | 55.3/100Mixed-positive evidence67% evidence | BREAKING OUT | 19.5/35 Income 16.9% · PAT 13.8% 52% evidence | 12.4/25 ROA — · ROE 9.3% · GNPA — 34% evidence | 5.3/20 P/BV 3.39× · P/BV÷ROE 0.37 100% evidence | 18.1/20 RS sector 7.6% · RS bench 6.1% · 1Y -6.2%10 of 12 weeks ahead 100% evidence |
| Exact sum: 19.5 + 12.4 + 5.3 + 18.1 = 55.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 8Bajaj Holdings & Investment LtdBAJAJHLDNG | 51.1/100Mixed-positive evidence61% evidence | BREAKING OUT | 17.9/35 Income 30.3% · PAT 5.6% 52% evidence | 13.8/25 ROA — · ROE 11.9% · GNPA — 34% evidence | 11.4/20 P/BV 1.69× · P/BV÷ROE 0.14 100% evidence | 8.0/20 RS sector -9.6% · RS bench 2.5% · 1Y -13.9%5 of 11 weeks ahead 70% evidence |
| Exact sum: 17.9 + 13.8 + 11.4 + 8 = 51.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 9Tata Investment Corporation LtdTATAINVEST | 49.0/100Mixed-negative evidence88% evidence | ASLEEP | 26.8/35 Income 31.6% · PAT 31.4% 86% evidence | 11.9/25 ROA 1.3% · ROE 1.4% · GNPA — 72% evidence | 4.1/20 P/BV 1.13× · P/BV÷ROE 0.79 100% evidence | 6.2/20 RS sector -4.3% · RS bench -5.7% · 1Y -3.7%2 of 12 weeks ahead 100% evidence |
| Exact sum: 26.8 + 11.9 + 4.1 + 6.2 = 49 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -4.3% and the one-year return is -3.7%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 10Maharashtra Scooters LtdMAHSCOOTER | 46.6/100Mixed-negative evidence61% evidence | BREAKING OUT | 22.4/35 Income 41% · PAT 15.3% 52% evidence | 10.8/25 ROA — · ROE 1.1% · GNPA — 34% evidence | 3.1/20 P/BV 0.54× · P/BV÷ROE 0.51 100% evidence | 10.3/20 RS sector -0.4% · RS bench -4.1% · 1Y -21.5%4 of 10 weeks ahead 70% evidence |
| Exact sum: 22.4 + 10.8 + 3.1 + 10.3 = 46.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 11Vardhman Holdings LtdVHL | 42.3/100Mixed-negative evidence80% evidence | TURNING | 8.5/35 Income 5.3% · PAT 1.6% 81% evidence | 14.4/25 ROA 5.8% · ROE 5.9% · GNPA — 68% evidence | 8.0/20 P/BV 0.29× · P/BV÷ROE 0.05 100% evidence | 11.4/20 RS sector -0.3% · RS bench -0.9% · 1Y -14.4%1 of 10 weeks ahead 70% evidence |
| Exact sum: 8.5 + 14.4 + 8 + 11.4 = 42.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 12Rane Holdings LtdRANEHOLDIN | 39.9/100Mixed-negative evidence61% evidence | BREAKING OUT | 14.8/35 Income 25.8% · PAT -50.8% 52% evidence | 11.4/25 ROA — · ROE 7% · GNPA — 34% evidence | 5.0/20 P/BV 2.1× · P/BV÷ROE 0.3 100% evidence | 8.7/20 RS sector -10.9% · RS bench 20.3% · 1Y 13.1%10 of 10 weeks ahead 70% evidence |
| Exact sum: 14.8 + 11.4 + 5 + 8.7 = 39.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 13Max India LtdMAXIND | 39.6/100Mixed-negative evidence63% evidence | BASING | 25.0/35 Income 36.3% · PAT 5.7% 52% evidence | 4.0/25 ROA -18.2% · ROE -32.8% · GNPA — 68% evidence | 8.3/20 P/BV 1.88× · P/BV÷ROE — 40% evidence | 2.3/20 RS sector -12.7% · RS bench -14% · 1Y -33.4%4 of 12 weeks ahead 100% evidence |
| Exact sum: 25 + 4 + 8.3 + 2.3 = 39.6 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -12.7% and the one-year return is -33.4%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 14Kalyani Investment Company LtdKICL | 37.1/100Mixed-negative evidence65% evidence | FADING | 11.2/35 Income -1.2% · PAT -36.7% 54% evidence | 6.7/25 ROA 0.3% · ROE 0.4% · GNPA — 72% evidence | 5.0/20 P/BV 0.19× · P/BV÷ROE 0.51 70% evidence | 14.2/20 RS sector 3.7% · RS bench 1.3% · 1Y 6.3%7 of 10 weeks ahead 70% evidence |
| Exact sum: 11.2 + 6.7 + 5 + 14.2 = 37.1 · Decision use: Price leads the evidence: RS versus the benchmark is 1.3%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 15Elcid Investments LtdELCIDIN | 36.3/100Mixed-negative evidence82% evidence | BASING | 13.9/35 Income -8.7% · PAT 10.3% 86% evidence | 10.5/25 ROA 1.3% · ROE 1.2% · GNPA — 72% evidence | 8.6/20 P/BV 0.25× · P/BV÷ROE 0.21 70% evidence | 3.3/20 RS sector -7.1% · RS bench -8.4% · 1Y -19.4%2 of 12 weeks ahead 100% evidence |
| Exact sum: 13.9 + 10.5 + 8.6 + 3.3 = 36.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 16Pilani Investment & Industries Corporation LtdPILANIINVS | 25.0/100Adverse evidence71% evidence | BASING | 10.6/35 Income -15.1% · PAT -80% 54% evidence | 5.4/25 ROA 0.2% · ROE 0.2% · GNPA — 72% evidence | 4.1/20 P/BV 0.29× · P/BV÷ROE 1.45 70% evidence | 4.9/20 RS sector -9.6% · RS bench -10.8% · 1Y -18%0 of 12 weeks ahead 100% evidence |
| Exact sum: 10.6 + 5.4 + 4.1 + 4.9 = 25 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 17JSW Holdings LtdJSWHL | 24.6/100Adverse evidence82% evidence | BASING | 7.5/35 Income -26% · PAT -22.5% 86% evidence | 8.3/25 ROA 0.4% · ROE 0.5% · GNPA — 72% evidence | 4.4/20 P/BV 0.38× · P/BV÷ROE 0.83 70% evidence | 4.4/20 RS sector -21.9% · RS bench -23% · 1Y -39.3%0 of 12 weeks ahead 100% evidence |
| Exact sum: 7.5 + 8.3 + 4.4 + 4.4 = 24.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 18Max Financial Services LtdMFSL | 18.9/100Adverse evidence88% evidence | ASLEEP | 8.5/35 Income 4.9% · PAT -58.9% 86% evidence | 6.8/25 ROA 0.1% · ROE 1.5% · GNPA — 72% evidence | 0.4/20 P/BV 9.65× · P/BV÷ROE 6.35 100% evidence | 3.2/20 RS sector -6.8% · RS bench -7.9% · 1Y -6.4%0 of 12 weeks ahead 100% evidence |
| Exact sum: 8.5 + 6.8 + 0.4 + 3.2 = 18.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. Financial companies use P/BV÷ROE and asset quality; PEG, industrial OPM and ROCE are excluded. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is Godrej Industries Ltd's share price today?
Godrej Industries Ltd trades at ₹1,127, −6.9% over the past year. The company is valued at ₹37,956 Cr. The stock sits at 55% of its 52-week range of ₹775–₹1,418, +0.4% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 13 weeks in. — as of 11 September 2026.
What were Godrej Industries Ltd's latest quarterly results?
Godrej Industries Ltd reported total income of ₹5,448 Cr and net profit of ₹523 Cr for the Jun 26 quarter. Income rose 22.2% and profit fell 27.9% year on year. Earnings per share were ₹8.44. The net margin was 9.6%, 6.7 pp lower than a year earlier. — as of 11 September 2026.
What is Godrej Industries Ltd's revenue?
Godrej Industries Ltd reported revenue of ₹5,448 Cr in the Jun 26 quarter, +22.2% year on year. For the full FY26 fiscal year, revenue was ₹22,237 Cr (+13.1%). Over the last 10 years revenue compounded at 11.5% a year. — as of 11 September 2026.
What is Godrej Industries Ltd's profit?
Godrej Industries Ltd earned ₹523 Cr of net profit in the Jun 26 quarter, −27.9% year on year. Full-year FY26 profit was ₹2,412 Cr. The net margin ran 9.6% in the latest quarter. — as of 11 September 2026.
What is Godrej Industries Ltd's market cap?
Godrej Industries Ltd's market capitalisation is ₹37,956 Cr at a share price of ₹1,127. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 11 September 2026.
What is Godrej Industries Ltd's P/BV ratio?
Godrej Industries Ltd trades at a P/BV of 3.4×, at the 47th percentile of its own 11-year range, against a long-run median of 3.4×. This is a comparison with the stock's own history, not a value call — as of 11 September 2026.
Does Godrej Industries Ltd pay a dividend?
Not in its latest year — Godrej Industries Ltd's dividend payout was 0% of profit in FY26. It did record a payout in 6 of its last 13 reported fiscal years, so there is a history but no current dividend. This page holds the payout ratio, not a per-share amount. — as of 11 September 2026.
Is Godrej Industries Ltd overvalued?
On its own history, Godrej Industries Ltd looks mid-range: its P/BV of 3.4× sits at the 47th percentile of its 11-year range (long-run median 3.4×). That is a percentile read against the stock's own past, not a price opinion or a direction call. One caveat: the net margin is the best this company has ever printed — cheap on record margins is not the same thing as cheap. — as of 11 September 2026.
Is Godrej Industries Ltd growing?
Not right now — Godrej Industries Ltd's latest numbers are shrinking: latest-quarter revenue +22.2% year on year, profit −27.9%, and the net margin −6.7 pp at 9.6%. The 10-year compound rates are 11.5% (revenue) and 22.3% (profit). The earnings engine currently reads: deteriorating — as of 11 September 2026.
How is Godrej Industries Ltd performing?
Godrej Industries Ltd is in a confirmed uptrend, 13 weeks in. Its latest quarter's income rose 22.2% and profit fell 27.9% year on year. Against the NIFTY 500 it has been behind on a trailing-13-week view for 1 week. This describes what the data did, not a rating. — as of 11 September 2026.
What stage is Godrej Industries Ltd in?
Mixed — growth is normalizing off a hyper-growth base: profit growth has eased from +105.5% at its peak to +13.8% but is still expanding. The read comes from the last 12 quarters of growth (revenue growth +16.9% latest, profit growth +13.8% latest, eps growth +16.6% latest) plus the ROE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 11 September 2026.
Is Godrej Industries Ltd in an uptrend?
Yes — the price is in a confirmed uptrend (week 13 of stage 2), trading +0.4% versus its 200-day average and at 55% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 11 September 2026.
Is Godrej Industries Ltd beating the market?
Not lately — on a trailing-13-week view Godrej Industries Ltd is currently behind the NIFTY 500 (1 week and counting; last ahead the week of 2026-09-04), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.5 years the stock moved +240% against the NIFTY 500's +267% — behind the index over the full window. — as of 11 September 2026.
Will Godrej Industries Ltd's share price go up?
This page publishes no price forecast for Godrej Industries Ltd. What it measures instead: the share price is ₹1,127, the price is in a confirmed uptrend 13 weeks in. Its P/BV of 3.4× sits at the 47th percentile of its own 11-year range. — as of 11 September 2026.
Who owns Godrej Industries Ltd?
Promoters hold 74.6% of Godrej Industries Ltd, foreign institutions 4.6%, domestic institutions 3.5% and the public 17.3% (latest quarter). The biggest move on the register over the last two years: Promoters added 7.5 points over 8 quarters. — as of 11 September 2026.
Where is Godrej Industries Ltd in its business cycle?
Godrej Industries Ltd's FY26 net margin was 10.8%, against a 13-year band of 3.6%–10.8%: the top of the band — a record year. Record profitability is late-cycle territory: every ratio flatters at the top, and the story leans on margins holding. The latest quarter ran 9.6%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 11 September 2026.
What growth does Godrej Industries Ltd's price assume?
At its price on 29 June 2026, Godrej Industries Ltd was priced for profit growth of about 10.5% a year. Profit itself has compounded 22.3% a year over the past 10 years. The figure reads the multiple backwards: the growth a buyer at that price was already paying for. — as of 11 September 2026.
What could break the Godrej Industries Ltd story?
The sharpest disagreement: annual EPS moved +26.4% against a −6.9% price move — the market has not yet caught up with the delivery. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 11 September 2026.
Is Godrej Industries Ltd a stock worth studying right now?
This is not investment advice. The machine read: Godrej Industries Ltd's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it. The sharpest open question: whether the price catches up with earnings that have already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 11 September 2026.
Not SEBI Registered !! Not Investment advice !!